Innovative Grade US Origin CD-1 Mouse Serum Reference 12-24-08
Posted by Leanne Kodsman on
Innovative Research's Innovative Grade US Origin CD-1 Mouse Serum was recently used in the following study:
...to the upper compartments. The lower compartments were filled with 600 lDMEM-Nutridoma containing 10% mouse serum (Innovative Research, Inc., Novi, MI, USA) as a source of chemoattractants. The serum had been depleted...
Wnt signalling in mouse mesenchymal stem cells: impact on proliferation, invasion and MMP expression
M Karow, T Popp, V Egea, C Ries... - Journal of cellular ..., 2009 - Wiley Online Library...to the upper compartments. The lower compartments were filled with 600 lDMEM-Nutridoma containing 10% mouse serum (Innovative Research, Inc., Novi, MI, USA) as a source of chemoattractants. The serum had been depleted...
The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!
Related Posts
Photoreactive Carboxybetaine Copolymers Impart Biocompatibility and Inhibit Plasticizer Leaching on Polyvinyl Chloride
Pooled Human Complement Serum from Innovative Research was used in the following study:...
Read the ArticleIncorporation of Lateral Microfiltration with Immunoaffinity for Enhancing the Capture Efficiency of Rare Cells
Single Donor Human Whole Blood from Innovative Research was used in the following study...
Read the ArticleAnti-Coagulation Factor XI Antibodies
Innovative Grade US Origin Monkey Cynomolgus Plasma and Innovative Grade US Origin Monk...
Read the Article